Qing Ling Yu
Directeur Général chez Beijing Advaccine Biotechnology Co., Ltd.
Profil
Qing Ling Yu is currently the President, General Manager & Executive Director at Beijing Advaccine Biotechnology Co., Ltd.
Prior to this, she obtained an undergraduate degree from the University of International Business & Economics in 2001.
Postes actifs de Qing Ling Yu
Sociétés | Poste | Début |
---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Directeur Général | 08/04/2009 |
Formation de Qing Ling Yu
University of International Business & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
Health Technology |